Form 4 for CGEN COMPUGEN LTD
Accepted 2026-07-30 16:01:07 ET · period of report 2026-07-29 · accession 0001178913-26-003706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-30 16:01 | 2026-07-29 | CGEN | Mahler Michelle | Chief Medical Off | A - Grant | $0.00 | +13.5K | 36.6K | +58% | $0 |
| D | 2026-07-30 16:01 | 2026-07-29 | CGEN | Mahler Michelle | Chief Medical Off | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-29 | A | A | 13,500 | $0.00 | 36,625 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Derivative | Share Option (right to buy) | 2026-07-29 | A | A | 18,000 | $0.00 | 18,000 | D | $2.26 · — to 2036-07-29 | 18,000 Ordinary Shares | (F2) This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |